Key result
This editorial reviews recent advances in sport cardiology, highlighting the impact of exercise on cardiac remodeling, genetic testing in athletes, and physical activity for CVD prevention.
Answers are grounded in this paper and cite their sources.
This editorial summarizes recent evidence on sports cardiology, exercise physiology, and their roles in cardiovascular risk stratification and prevention across healthy individuals and various patient populations.
The present issue is focusing on the role of sport cardiology and exercise physiology in risk stratification and cardiovascular disease (CVD) prevention, considering both healthy individuals and patients with different pathological conditions. Long-term athletic training is linked to a markedly elevated haemodynamic demand, which results in structural, functional, and electrical adaptation known as the ‘athlete’s heart’. The amount of this remodelling has been traditionally considered balanced between the left and the right heart chambers.1 However, with intensive exercise, the right heart is subjected to disproportional afterload and wall stress, which may result in more dramatic exercise-induced alterations over time, data concerning the right ventricular (RV) mechanical changes and their continuum with athletic performance are scarce. In a here presented study, biventricular morphology and function and their relation to sex, age, and sports classes were characterized in a large cohort of elite athletes using three-dimensional (3D) echocardiography.2 Regular and intensive physical activity caused considerable and specific alterations in biventricular architecture and function. When compared with sedentary controls, resting left and RV functions were lower with a disproportionate decrease in RV circumferential shortening. Right ventricular volume was found to be the strongest independent predictor of functional capacity by multivariable linear regression. Despite being some of the fittest individuals in society, athletes paradoxically carry an increased risk of sudden cardiac death (SCD) when compared with sedentary individuals. High-intensity exercise can cause electrical and structural cardiac remodelling that mimics inherited cardiac diseases (ICCs), sometimes known as the ‘grey zone’. In this context, the differentiation between ‘athlete’s heart’ and pathology is crucial but it can be difficult and often necessitates the use of second- and third-line exams such as, for example, genetic testing. However, the role of genetic testing in the examination and care of athletes with suspected heart problems is still unclear. This position paper is intended for physicians, nurses, and other healthcare providers who are involved in the athlete's treatment, and it was developed to meet the needs of the sports cardiology community, the majority of whom work outside of specialized cardio-genetics centres.3 First, an introduction of the basic terminology and principles, as well as recommendations for the appropriate use of genetic testing in the athletes’ evaluation, is provided: it explains the critical factors to be considered in genetic testing, outlining potential benefits, drawbacks, and providing a road map. Afterwards, common clinical scenarios in sports cardiology practice are presented and discussed, including the diagnostic, prognostic, and therapeutic implications of genetic testing, as well as the impact on exercise recommendations. Long QT syndrome (LQTS) affects one out of every 2000 people and is distinguished by a prolonged QT interval plus syncope, seizures, or sudden cardiac death (SCD). Despite the fact that there are numerous LQTS susceptibility genes, pathogenic mutations in the three most frequent LQTS genes (KCNQ1, KCNH2, and SCN5A) account for 75–80% of all congenital LQTS. Because of the presumed increased risk of death associated with exercise, LQTS athletes should be disqualified from competitive sport in accordance with international recommendations. However, several evidence showed that young athletes with LQTS who continued to participate in competitive or recreational sports had very few, if any, adverse outcomes. There is a genotype-specific repolarization response to exercise and a variety of provocative testing. Exercise stress testing and abrupt postural alterations are increasingly being used in clinical diagnostics to improve phenotypic traits in LQTS patients. The present review describes the impact of exercise training, exercise stress, and posture adjustment therapies on ventricular repolarization in patients with LQTS.4 Overall, the authors confirmed that patients with LQT1, LQT2, and LQT3 have unique repolarization responses to sympathetic stress. LQT1 patients have the longest QT intervals at higher heart rates during exercise or at the beginning of recovery. Conversely, LQT2 and LQT3 patients have the most prolonged QT intervals at lower heart rates, such as a few minutes into recovery. These subtype-specific trends may come in handy when prescribing an exercise training programme for LQTS patients, as it may promote safety while allowing for the greatest health and quality-of-life benefits to be achieved. The cardiopulmonary exercise test (CPET) parameter exercise oscillatory ventilation (EOV), along with peak exercise oxygen consumption (peak VO2) and the ventilation vs. carbon dioxide production relationship (VE/VCO2 slope), can stratify the prognosis of patients with chronic heart failure and reduced ejection fraction (HFrEF). Exercise oscillatory ventilation, in particular, is a type of ventilation behaviour that is not uncommon in patients with advanced HFrEF, consisting of a regular waxing and waning of ventilation (hyperpnoea and hypopnoea), that may occur in two patterns during exercise: EOV persistence (P-EOV) and EOV dis-appearance (D-EOV). It is still unknown if patients with HFrEF with P-EOV have distinct clinical and CPET responses, as well as different prognostic characteristics when compared with D-EOV or no EOV patients (N-EOV). Here, da Luz Goulart et al.5 evaluated the influence of EOV in HFrEF patients determining the effect of P-EOV and D-EOV on the outcomes of mortality and hospitalization in these patients. They confirmed that patients with HFrEF and EOV have an increased risk of mortality and hospitalization, more severe symptoms, and a poorer LV function than those with N-EOV. Furthermore, among patients with EOV, those with P-EOV have a poorer clinical status, exercise performance, and prognosis than those with D-EOV. The prediction of maximal heart rate (MHR) is the initial step in defining chronotropic incompetence. Both the MHR prediction and the definition of chronotropic incompetence are unresolved difficulties in the clinical practice of HFrEF evaluation, as they are modified by therapy, disease-specific characteristics, and patient fitness. Currently, the historical equation by Fox [MHR predicted = (220–age)] is still frequently employed to determine the MHR, despite the fact that it has not been validated in specific clinical scenarios. Only Keteyian et al.6 derived a population-specific formula for the MHR prediction in HFrEF on optimized β-blockers treatment. In this issue of the journal, using the MECKI (Metabolic Exercise combined with Cardiac and Kidney Indexes) database,7 a new equation for the MHR prediction [(MHR = [109 + (0.5*HR rest) − (0.5*age) + (0.2*LVEF) (−5 if Hb, 11 g/dL)] was derived which performed significantly better than other formulas (e.g. Fox and Tanaka formulas) and also slightly better than Keteyian formula.8 Furthermore, the 75–80% range of MHR estimated with the new and the Keteyian formulas identified precisely the HR at the anaerobic threshold computed during symptom-limited CPET in HFrEF patients. The obesity paradox refers to current research suggesting that obesity may be beneficial and associated with lower mortality in older people or those with chronic pathological conditions.9 However, studies on the obesity paradox have raised questions whether this relation exists or it is just an epiphenomenon or effect of reverse epidemiology. Furthermore, physical fitness may significantly affect the association between body mass index (BMI) and mortality in men. To explore the role of physical fitness in the obesity paradox in women with ischaemic heart disease (IHD), Quesada et al.10 used the Women’s Ischemia Syndrome Evaluation (WISE) cohort. They confirmed that, compared with normal BMI-fit, normal BMI-unfit women had higher MACE risk, whereas obese-fit and overweight-fit women had a lower risk of mortality. These findings broaden the obesity paradox to include women with IHD and suggest that physical fitness may play a role in the obesity paradox. Epidemiological studies have shown that lower systolic blood pressure, weight loss, smoking cessation, education, and a balanced diet all reduce the incidence of CVD. The link between physical exercise and CVD has received a lot of attention in recent years. Previous research, for example, has shown that physical activity improves the prognosis of CVD in both healthy participants and in those with traditional risk factors. Furthermore, physical exercise has a dose–response relationship with the risk of CVD. Nevertheless, the impact of physical activity among people at high or intermediate CVD risk has not been fully explored. In the current issue, the authors estimated the association between physical activity and CVD risk overall and in individuals with and without risk factors.11 A total of 13 041 CVD cases and 15 486 non-cases from eight countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) study were analysed. They discovered that moderate physical exercise was related with a reduced risk of coronary heart disease in people with and without CVD risk factors. Any level of physical activity above full inactivity reduced the risk of coronary heart disease among participants with risk factors but did not eliminate the CVD risk entirely. The highest degree of physical activity did not appear to reduce the risk of coronary heart disease any further than moderate levels of physical activity.
No takes yet. Share an insight, caveat, or question.
Hálasz et al. (2022) conducted an editorial in Cardiovascular disease. Sport cardiology and exercise was evaluated. This editorial reviews recent advances in sport cardiology, highlighting the impact of exercise on cardiac remodeling, genetic testing in athletes, and physical activity for CVD prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: